- Home
- ASGN vs ALVO Comparison
ASGN vs ALVO Comparison
Compare ASGN & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASGN
- ALVO
- Stock Information
- Founded
- ASGN 1985
- ALVO 2013
- Country
- ASGN United States
- ALVO Luxembourg
- Employees
- ASGN N/A
- ALVO N/A
- Industry
- ASGN Professional Services
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- ASGN Consumer Discretionary
- ALVO Health Care
- Exchange
- ASGN Nasdaq
- ALVO Nasdaq
- Market Cap
- ASGN 2.3B
- ALVO 2.5B
- IPO Year
- ASGN 1992
- ALVO N/A
- Fundamental
- Price
- ASGN $49.60
- ALVO $8.69
- Analyst Decision
- ASGN Hold
- ALVO Buy
- Analyst Count
- ASGN 6
- ALVO 1
- Target Price
- ASGN $63.67
- ALVO $18.00
- AVG Volume (30 Days)
- ASGN 525.8K
- ALVO 301.3K
- Earning Date
- ASGN 07-23-2025
- ALVO 08-14-2025
- Dividend Yield
- ASGN N/A
- ALVO N/A
- EPS Growth
- ASGN N/A
- ALVO N/A
- EPS
- ASGN 3.52
- ALVO 0.34
- Revenue
- ASGN $4,019,000,000.00
- ALVO $587,890,000.00
- Revenue This Year
- ASGN N/A
- ALVO $36.18
- Revenue Next Year
- ASGN $2.89
- ALVO $42.61
- P/E Ratio
- ASGN $13.72
- ALVO $25.58
- Revenue Growth
- ASGN N/A
- ALVO 413.92
- 52 Week Low
- ASGN $46.64
- ALVO $7.35
- 52 Week High
- ASGN $105.00
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- ASGN 44.08
- ALVO 41.42
- Support Level
- ASGN $46.64
- ALVO $8.37
- Resistance Level
- ASGN $50.10
- ALVO $8.91
- Average True Range (ATR)
- ASGN 1.56
- ALVO 0.33
- MACD
- ASGN -0.02
- ALVO 0.02
- Stochastic Oscillator
- ASGN 33.91
- ALVO 32.26
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.